In summary, we show that tumor PD-L1 effects are considerably broader than simply blunting PD-1+ anti-tumor T-cell activities and suggest many additional avenues for investigations of tumor immunopathogenesis, treatment approaches and potentially treatment responses. Here, CD274 is linked to neoplasm.